AbbVie and Pfizer both have great dividends and successful track records over the long run. But which is the better pick now?
What dividend stocks look like buys right now? Check out AT&T, Intel, and AbbVie.
AbbVie (ABBV) announces Mavyret's sanction in Canada for treatment of HCV across all major genotypes. This gain serves a big boost to the company's product portfolio.